Cure My Disease

Don't miss your cure!

 Log in / Sign up

Less invasive shoulder surgery could match standard procedure for active patients

NCT ID NCT07715162

Disease control Sponsor: Clinique Générale dAnnecy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This trial compares two surgical techniques for people with recurrent anterior shoulder instability and mild (subcritical) bone loss. One is the arthroscopic Latarjet procedure, which uses a bone graft to restore the shoulder socket. The other is dynamic anterior stabilization (DAS), a less invasive method that reroutes a tendon to stabilize the joint. The study will measure quality of life and function over 24 months to see if DAS offers similar results with fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
two surgical procedures: dynamic anterior stabilization (DAS) and the arthroscopic Latarjet procedure
What this could lead to
If DAS proves as effective as the Latarjet procedure, it could offer a less invasive surgical option with fewer complications for people with recurrent shoulder instability and mild bone loss.
What could go wrong
This is a relatively small trial (84 participants), and the results may not apply to all patients. Both surgeries carry risks like infection, nerve damage, or recurrence of instability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Nov 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * aged 18 or older * with symptomatic recurrent anterior shoulder instability indicating the need for surgical stabilization * whose glenoid bone loss must be classified as subcritical, approximately between 13.5% and 20%, according to the criteria defined in the protocol * with HAGL lesions * with bone lesions * capable of providing informed consent and complying with the planned 24-month follow-up Exclusion Criteria: * with glenoid bone loss exceeding 20% * with a clear indication for another procedure not covered by the protocol (particularly if routine bone grafting is required and incompatible with the study) * with a history of bone stabilization of the affected shoulder * with a transfixing rotator cuff tear or a neurological condition impairing shoulder function * unable to guarantee adequate follow-up * under legal guardianship (curatorship, guardianship, or judicial protection) * deprived of liberty by judicial or administrative order * receiving psychiatric care * not enrolled in a social security program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anterior shoulder instability are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anterior shoulder instability

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.